23K protein with binding specificity for queuine
AssigneeLa Jolla Cancer Research Foundation
InventorR. Douglas Armstrong
Life of this patent
Estimating the term…
Abstract
The invention generally relates to the discovery of a 23 kD protein, designated herein as Queb, that has specific binding affinity for the purine base Queuine. The invention particularly relates to polypeptides having specific binding reactivity with Queuine and methods of using such polypeptides to purify Queuine and Queuine-containing substances. The invention also relates to antibodies having specific reactivity with Queuine or Queb. Methods for determining the presence and concentration of Queuine and Queb are also provided as well as methods for the diagnosis of a pathological disease or prognosis of a patient having a disease associated with Queuine, Queuine-containing substances such as Queuine-tRNA, or Queb. Kits useful for performing the methods of the present invention are also provided.
Claims5
A substantially pure non-antibody polypeptide having specific binding reactivity with Queuine said polypeptide having a molecular weight of about 23 kD.
A substantially pure non-antibody peptide having specific binding reactivity with Queuine, said peptide containing an amino acid sequence of substantially the sequence EGSDNQPNGXTNPN.
A method for purifying a non-antibody polypeptide having specific binding reactivity with Queuine, comprising:
- (a) contacting a sample containing said polypeptide with insolubilized Queuine or antibody having specific reactivity with said polypeptide;
- (b) separating bound polypeptide from unbound components of the sample;
- (c) detaching bound polypeptide from the insolubilized Queuine or antibody;
- and
- (d) collecting purified polypeptide.
Dependencies are inferred from the claim text.